RAC1 and inflammatory bowel disease: In this explorative, observational study conducted in IBD patients subdivided into drug-classified groups, a remarkable, but theoretically predicted suppression of Rac1-corrected pSTAT3 protein levels in T lymphocytes of almost 50% were found in IBD patients in remission on thiopurine maintenance therapy, when compared to IBD patients with active disease.